Macrophage Activation Syndrome, Glomerulonephritis, Pericarditis, and Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus

被引:5
作者
Luo, Yiming [1 ]
Wen, Yumeng [1 ]
Molina, Ana Belen Arevalo [1 ]
Dahal, Punya [1 ]
Leuprecht, Lorenz [1 ]
Bsrat, Makda [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Med, Mt Sinai St Lukes & Mt Sinai West, New York, NY 10029 USA
关键词
D O I
10.1155/2018/5979386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage activation syndrome (MAS) is a rare manifestation of systemic lupus erythematosus (SLE) with potentially life-threatening consequences. To the best of our knowledge, this is the first case reported in literature for a constellation of MAS, glomerulonephritis, pericarditis, and retinal vasculitis as initial presentation of SLE. Despite extensive multisystem involvement of his disease, the patient responded well to initial steroid treatment, with mycophenolate mofetil successfully added as a steroid-sparing agent. Our case highlights the importance of multispecialty collaboration in the diagnosis and management of SLE with multisystem involvement.
引用
收藏
页数:5
相关论文
共 24 条
[1]  
Arevalo J Fernando, 2002, Curr Opin Ophthalmol, V13, P404, DOI 10.1097/00055735-200212000-00011
[2]   Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus [J].
Bakshi, J. ;
Hassan, S. ;
D'Cruz, D. ;
Chan, A. .
LUPUS, 2013, 22 (14) :1544-1546
[3]  
Dubuc CAE, 2014, REUMATOL CLIN, V10, P321, DOI [10.1016/j,reuma.2013.19.004, 10.1016/j.reuma.2013.09.004]
[4]  
Ermakova N A, 2001, Vestn Oftalmol, V117, P21
[5]   Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome [J].
Fardet, Laurence ;
Galicier, Lionel ;
Lambotte, Olivier ;
Marzac, Christophe ;
Aumont, Cedric ;
Chahwan, Doumit ;
Coppo, Paul ;
Hejblum, Gilles .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2613-2620
[6]  
Filipovich Alexandra H, 2009, Hematology Am Soc Hematol Educ Program, P127, DOI 10.1182/asheducation-2009.1.127
[7]   Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases [J].
Fukaya, S. ;
Yasuda, S. ;
Hashimoto, T. ;
Oku, K. ;
Kataoka, H. ;
Horita, T. ;
Atsumi, T. ;
Koike, T. .
RHEUMATOLOGY, 2008, 47 (11) :1686-1691
[8]   Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients [J].
Gavand, Pierre-Edouard ;
Serio, Ilaria ;
Arnaud, Laurent ;
Costedoat-Chalumeau, Nathalie ;
Carvelli, Julien ;
Dossier, Antoine ;
Hinschberger, Olivier ;
Mouthon, Luc ;
Le Guern, Veronique ;
Korganow, Anne-Sophie ;
Poindron, Vincent ;
Gourguechon, Clement ;
Lavigne, Christian ;
Maurier, Francois ;
Labro, Guylaine ;
Heymonet, Marie ;
Artifoni, Matthieu ;
Viau, Amelie Brabant ;
Deligny, Cristophe ;
Sene, Thomas ;
Terriou, Louis ;
Sibilia, Jean ;
Mathian, Alexis ;
Bloch-Queyrat, Coralie ;
Larroche, Claire ;
Amoura, Zahir ;
Martin, Thierry .
AUTOIMMUNITY REVIEWS, 2017, 16 (07) :743-749
[9]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[10]   Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis [J].
Henzan, T ;
Nagafuji, K ;
Tsukamoto, H ;
Miyamoto, T ;
Gondo, H ;
Imashuku, S ;
Harada, M .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (01) :59-61